Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hanyang Lin
Selective JAK2/ABL Dual Inhibition Therapy Effectively Eliminates TKI-insensitive CML Stem/Progenitor Cells
Oncotarget
Oncology
Related publications
Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms
Clinical Cancer Research
Cancer Research
Oncology
Adherence to BCR-ABL Inhibitors: Issues for CML Therapy
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Preferential Sequestration in Vitro of BCR/ABL Negative Hematopoietic Progenitor Cells Among Cytokine Nonresponsive CML Marrow CD34+ Cells
Bone Marrow Transplantation
Transplantation
Hematology
Dual Inhibition of Jak2 and STAT5 Enhances Killing of Myeloproliferative Neoplasia Cells
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Combined Inhibition of MDM2 and BCR-Abl Tyrosine Kinase Targets Chronic Myeloid Leukemia Stem/Progenitor Cells in a Murine Model
Haematologica
Hematology
Inhibition of USP2 Eliminates Cancer Stem Cells and Enhances TNBC Responsiveness to Chemotherapy
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Homing in on CML Stem Cells
Science-Business eXchange
Inhibition of the BCR-Abl Tyrosine Kinase as a Therapeutic Strategy for CML
Oncogene
Cancer Research
Genetics
Molecular Biology
Notch Inhibition Prevents Differentiation of Human Limbal Stem/Progenitor Cells in Vitro
Scientific Reports
Multidisciplinary